Ubiquitylation is crucial for proper cellular responses to DNA double-strand breaks (DSBs). If unrepaired, these highly cytotoxic lesions cause genome instability, tumorigenesis, neurodegeneration or premature ageing. Here, we conduct a comprehensive, multilayered screen to systematically profile all human ubiquitin E2 enzymes for impacts on cellular DSB responses. With a widely applicable approach, we use an exemplary E2 family, UBE2Ds, to identify ubiquitylation-cascade components downstream of E2s. Thus, we uncover the nuclear E3 ligase RNF138 as a key homologous recombination (HR)-promoting factor that functions with UBE2Ds in cells. Mechanistically, UBE2Ds and RNF138 accumulate at DNA-damage sites and act at early resection stages by promoting CtIP ubiquitylation and accrual. This work supplies insights into regulation of DSB repair by HR. Moreover, it provides a rich information resource on E2s that can be exploited by follow-on studies.
. One principal DSB-repair mechanism is non-homologous end-joining (NHEJ), which is active throughout the cell cycle and occurs through two pathways: classical NHEJ and alternative/microhomology-mediated end-joining 3 (MMEJ). The other, homologous recombination (HR), requires a sister chromatid as a template and is limited to S/G 2 cellcycle phases 2 . Key to initiating HR is DNA-end resection promoted by CtIP (RBBP8) recruitment to DSB sites 2, 4, 5 , yielding single-stranded DNA (ssDNA) that is rapidly bound by RPA and subsequently replaced by RAD51, leading to strand invasion and ensuing HR processes 2 . Precisely how CtIP and early HR events are regulated, however, is not known.
Among the earliest DDR events is activation of the protein kinases ATM, ATR and DNA-PKcs (ref. 6) . Activated ATM phosphorylates histone H2AX (H2AFX) to yield γH2AX at DSBs, which in turn recruits numerous DDR modulators into ionizing-radiation-induced foci 1, 2, 7 (IRIF). Recently, ubiquitylation has emerged as a key DDR regulator 8 . Mediated by 2 E1-activating, ∼40 E2-conjugating and >600 E3-ligating enzymes, post-translational modification by ubiquitin modulates the stability, localization, activity or interaction properties of proteins 9, 10 . E2s, previously regarded as mere basic ubiquitylation components, have recently emerged as key ubiquitylation mediators. E2-E3 pairs exist in various combinations, controlling the switch between ubiquitin-chain initiation and elongation, and determining ubiquitylation processivity and linkage specificity 11, 12 . Despite the above, few systematic analyses of human E2s or E3s have been conducted, although recent proteomic approaches have identified hundreds of DDR-regulated ubiquitylation substrates 13 , suggesting that E2s and many E3s with DDR roles await discovery.
Here, using a three-module, short interfering RNA (siRNA)-based, semi-automated analysis pipeline, we systematically interrogate E2s for DSB-response functions in human cells. In addition to identifying various E2s with previously non-established DDR functions, we show how such data can be used to identify E2-E3-substrate ubiquitylation pathways. Specifically, by applying data-mining and phenotypicmimicry approaches, we identify the ubiquitin E3 ligase RNF138 as a DDR factor that cooperates with UBE2Ds to promote HR by stimulating CtIP ubiquitylation and accrual at DSB sites.
RESULTS

Systematic multi-module screen for DDR E2s
To identify E2 DDR components, we performed loss-of-function screens in U2OS cells with siRNA pools targeting 37 E2s, control siRNA (CTRL siRNA) and validated siRNAs against known DDR factors (Supplementary Table 1 ). We evaluated siRNA treatments of all known ubiquitin E2s and the two NEDD8 E2s, UBE2M and UBE2F. To obtain comprehensive DDR 'fingerprints' we multiplexed the screen into three modules. Data represent averages ± range of n = 8 (CTRL siRNA and siRNF8+168) or n = 2 (all other siRNAs) 96-plate wells of, on average, 704 imaged cells per siRNA based on one screening experiment. Note that siD3-2 co-depletes all UBE2Ds and siD2-1 co-depletes UBE2D2, UBE2D3 and, to a lesser extent, UBE2D1 ( Supplementary Fig. 4a ). See Supplementary  Fig. 1c and PubChem BioAssays in the Methods for a comprehensive overview of screening data. siG2: siUBE2G2.
Module 1 evaluated impacts of E2 depletions on IRIF kinetics for DDR factors/markers by semi-automated, quantitative highcontent, high-throughput (HC/HT) microscopy ( Fig. 1a and Supplementary Fig. 1a,b) . Ninety-six-well plates containing duplicates for each E2 siRNA were irradiated or not, fixed and assessed for γH2AX IRIF (a DNA-damage marker), 53BP1 (TP53BP1) whose DNAPKi  MG132  DNAPK  CtIP  LIG-III-1  LIG-III-2  T  D3  *   R2  V2  D1  J1  O  L6  R1  N  H  U  V1  L3  F  Q2  BIRC6  NL  A  K  TSG101  E3  G1  AKTIP  G2 D2 Figure 2 Screening E2s for DSB repair. (a) Schematic of the pipeline for the module 2 TLR assay 14, 15 . (b) TLR results for HR. Note that, as HR can occur only in S/G 2 , data were corrected to flow-cytometry S/G 2 values. Grey rectangles highlight control siRNA oligonucleotides; dashed line represents arbitrary cutoff at 60%. Data represent means ± s.d. for, on average, n = 5 biological experiments for controls and a minimum of n = 3 for E2 siRNAs. See Supplementary Table 2 for precise n values for each condition. (c) TLR results for mutEJ. Grey rectangle highlights control siRNAs; dashed line represents arbitrary cutoff at 60%. Data represent means ± s.d. for, on average, n = 5 biological experiments for controls and a minimum of n = 3 for E2 siRNAs. See Supplementary Table 2 for precise n values for each condition. Note: depleting the NHEJ factor DNA-PKcs or MMEJ factor ligase III (ref. 3) did not affect mutEJ significantly, suggesting that both pathways act redundantly in this assay. Note that siD3-2 co-depletes all UBE2Ds and siD2-1 co-depletes UBE2D2, UBE2D3 and, to a lesser extent, UBE2D1 ( Supplementary Fig. 4a ). See PubChem BioAssays in the Methods for a comprehensive overview of screening data.
IRIF require ubiquitin 8 , and conjugated ubiquitin (FK2 antibody). Validating the screening pipeline, depleting the ubiquitin E3s RNF8 and RNF168, or depleting UBE2N that has known DDR connections, strongly impaired FK2 and 53BP1 but not γH2AX IRIF (Fig. 1b (Fig. 1b and Supplementary Fig. 1c , PubChem BioAssays in the Methods and Discussion). Depleting UBE2D, -R, -J, -Q1, -Q2, UBE2O or -K reduced induction of FK2 IRIF to <25% of CTRL siRNA, whereas siUBE2D3 reduced FK2 IRIF induction by >97% (Fig. 1b,c ; siUBE2D3 is highlighted because we subsequently found that it depleted all UBE2D family members). Collectively, these results suggested that many E2s impact on DDR IRIF, particularly FK2-ubiquitin foci (Fig. 1b,c and Supplementary  Fig. 1c and PubChem BioAssays in the Methods).
Module 2 evaluated HR and mutagenic end-joining (mutEJ) by the traffic-light-reporter (TLR) system in U2OS cells 14, 15 ( Fig. 2a ; as HR operates only in S/G 2 , data were corrected to flow-cytometry S/G 2 values). Positive controls of ATM inhibition or CtIP depletion significantly decreased HR (refs 4,16) , whereas DNA-PK inhibition decreased mutEJ, possibly through DNA-PK retention at DSBs impeding access of other factors. Furthermore, the proteasome inhibitor MG132 markedly impaired HR, highlighting the importance of ubiquitylation in HR (ref. 17) . In agreement with this, we found that depleting many E2s markedly inhibited HR (Fig. 2b and  Supplementary Table 2 and PubChem BioAssays in the Methods). Furthermore, depleting several E2s, most notably UBE2O and -R2, strongly impaired mutEJ (Fig. 2c and Supplementary Table 2) .
Module 3 measured DDR signalling triggered by ionizing radiation treatment that generates DSBs throughout the cell cycle, or camptothecin (CPT), a topoisomerase I poison that yields S-phase DSBs, which are repaired by HR and activate ATR. DDR read-outs employed were CHK1 (CHEK1) phosphorylated on Ser 345 (pCHK1, a marker for ATR activation), RPA2 phosphorylated on Ser 4 and Ser 8 (pRPA2, a resection marker) and KAP1 (TRIM28) phosphorylated on Ser 824 (pKAP1, mainly ATM-dependent). γH2AX and cyclin A (CCAN2) were used as markers for DNA-damage induction and cells in S/G 2 , respectively ( Fig. 3a and Supplementary Fig. 2a-d) . As expected 4 , siCtIP reduced pRPA2 and pCHK1 but not γH2AX or pKAP1 following CPT treatment ( Fig. 3b and Supplementary Fig. 2a4 ). BRCA1 depletion decreased pCHK1 induction and, consistent with recent findings indicating that BRCA1 functions mainly downstream of resection initiation [18] [19] [20] [21] [22] , strongly reduced HR (7.91% ± 4.45% s.d. of CTRL siRNA, n = 4) but not CPT-induced pRPA2 ( Fig. 3b and Supplementary Fig. 2a4 ).
Strikingly, many E2 siRNAs affected CPT-and ionizing-radiationinduced DDR signalling, with pCHK1 effects following CPT generally correlating with reduced pRPA2 (Fig. 3b,c) . Of the 37 E2 depletions, many produced >40% reductions in pRPA2 following CPT (20 E2s), pCHK1 following CPT (21 E2s) or pCHK1 after ionizing radiation treatment (17 E2s; Fig. 3d ; see examples in Fig. 3e ). Decreased CPT-induced pCHK1 sometimes correlated with impaired pKAP1 and γH2AX induction, possibly reflecting lower S-phase indices ( Supplementary Fig. 2a,c) . Notably, however, 10 E2 siRNAs affected all 3 DDR read-outs (Fig. 3d) but not ionizing-radiation-induced pKAP1 and γH2AX ( Fig. 3c and Supplementary Fig. 2a1-4,d) , indicating that the targeted E2s are likely to possess DDR functions. These included UBE2N, -O, -V2, -D, -R, -L and -J family members, plus UBE2T and -W linked to the Fanconi anaemia DNA-repair pathway 23, 24 . These results thus highlighted potential roles of many E2s in ATR signalling, consistent with ubiquitylation promoting ATR activation 25 . In contrast, the main mark affected by siUBE2S or siBIRC6 was pKAP1 (both after CPT or ionizing radiation treatment; Fig. 3c ,e and Supplementary Fig. 2a3-4,d) , suggesting that these E2s may promote ATM signalling.
Validating DDR functions for selected E2s
To help interpret screen read-outs, we represented them in a Circos plot (Fig. 4a) . Here, E2 siRNAs are plotted clockwise in order of decreasing DDR impact (segment colours and breadths reflect cumulative impacts based on module read-outs) and E2 siRNAs scoring in the top 25% of all read-outs are connected by ribbons to the respective colour-coded read-out (further details in Fig. 4a ). Thus, it is clear that many E2-siRNA treatments affected HR, with various E2 siRNAs also impairing FK2 IRIF. In contrast, mutEJ effects were less pronounced, possibly reflecting the lower complexity of end-joining than HR.
To validate the value of our screening data for future studies, we selected E2 families where at least one family member had ≥3 connecting Circos plot ribbons (Fig. 4a) . Excluding UBE2N and -V1, owing to their defined DDR functions 8 , this group comprised UBE2D, -R, -J and -L members, and UBE2O. Importantly, these 11 E2 siRNAs efficiently depleted their targets and, apart from UBE2Ds, no marked cross-depletions were detected ( Supplementary Figs 3 and 4a) . In contrast, several siRNAs designed to target a particular UBE2D significantly co-depleted other UBE2Ds ( Supplementary Fig. 4a ), reflecting their high sequence homology at the messenger RNA (77-86% coding-sequence identity) and protein levels ( Supplementary  Fig. 4b ). Indeed, we noted that siRNAs targeting UBE2D3 efficiently depleted all UBE2Ds. Similarly, an siRNA designed to target UBE2D2 depleted both UBE2D2 and -D3 and had some effect on UBE2D1 ( Supplementary Fig. 4a ). Although some siUBE2Ds may have unique DDR functions, on the basis of their high degree of sequence homology, it seems likely that they have largely overlapping functions. To avoid potential redundancy issues of UBE2D proteins and strengthen screening data in follow-up experiments, we established an siRNA mixture (siALL-Ds) that efficiently depleted all UBE2Ds ( Supplementary Fig. 4c,d) . Importantly, when we tested the 11 siRNAs with the strongest DDR impacts for potential effects on RAD51, a key HR factor and a common 'off-target' for many siRNAs (ref. 26) , none caused a pronounced reduction in RAD51 (Supplementary Fig. 4e ).
We next explored DDR functions for selected E2s by live imaging of cells expressing GFP-tagged E2s. This revealed that various UBE2R, -L and -D family members exhibited both nuclear and cytoplasmic localizations, and were rapidly recruited to DSBs induced by laser micro-irradiation ( Fig. 4b ; recruitments were weak and detected best between 5 and 30 min). In contrast, UBE2O, -J1 and -J2 were largely cytoplasmic and not detected at laser tracts. Thus, >70% (8 of 11) of the selected E2s and 100% of the nuclear ones (UBE2R1, -R2, -L3, -L6, -D1, -D2, -D3 and -D4) accumulated at DSB sites (previously, only UBE2N, -A and -B were shown to do this 27, 28 ; note that, although overexpressed UBE2J1, -J2 and UBE2O were preferentially cytoplasmic and were not chosen for further analysis, they may impact on the DDR indirectly, or function directly in the DDR requiring associated factors for nuclear localization). We then examined the eight selected DNA-damage-recruited E2s functionally by assessing their impact on proliferation/cell growth after ionizing radiation treatment. This 
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CTRL siRNA siUBE2K Supplementary Fig. 2a . Results represent ratios of phosphorylated over total protein levels, for example, phospho-CHK1/total CHK1, which were normalized to the corresponding ratio of CTRL siRNAtreated cells and from which the equivalent ratios in undamaged cells were subtracted. In b, negative control siRNA (CTRL siRNA) and positive controls are highlighted in red and blue, respectively. Grey background shows regions of >40% reductions. In c, the grey rectangle highlights controls and the dashed red line indicates arbitrary cutoff at 60%. (d) Overlaps of E2 siRNAs scoring with >40% reductions in the indicated module 3 read-outs. (e) Whole cell extract (WCE) immunoblot examples for selected E2-siRNA pools based on one screening experiment. Red frames highlight key read-outs that the indicated E2-siRNA pools score in, based on their quantification by densitometry as indicated in b and c. Dotted red frame indicates that only one of the two E2-siRNA pools shows a clear phenotype in the indicated read-out. Note: siD3-2 co-depletes all UBE2Ds and siD2-1 codepletes UBE2D2, UBE2D3 and, to a lesser extent, UBE2D1 ( Supplementary  Fig. 4a ). See PubChem BioAssays in the Methods for a comprehensive overview of quantitative screening data.
revealed that depleting UBE2R1, -R2, -L3 or -L6 with at least two independent siRNAs caused ionizing radiation hyper-sensitization, in some cases comparable to siATM (Fig. 4c) . This was also so for codepleting UBE2Ds. Collectively, these results supported there being important DDR functions for UBE2R1, -R2, -L3, -L6 and -Ds.
DNA-end resection links UBE2Ds to RNF138
Owing to their strong phenotypes in multiple screen read-outs, we focused subsequent studies on the UBE2D family, co-depleting them with siALL-Ds. In line with our pRPA2 data, depleting UBE2Ds strongly decreased CPT-induced formation of ssDNA and nuclear 51 ; see legend on top right of the panel. (I) Legend for E2-siRNA segments (arranged clockwise underneath the grey arrow on the right half of the Circos plot according to decreasing overall DDR effects). Outer bar: colour indicates read-outs that this E2 siRNA scores in; elements are ordered clockwise for decreasing contributions of individual read-outs giving a cumulative impact for each E2 siRNA; width of element indicates strength of phenotype. E2 siRNA: colour-coded; segment width reflects cumulative impact of all read-outs that the respective E2 siRNA scores in; ordered clockwise for E2 siRNAs with decreasing cumulative impact. Ribbons: colours according to read-out, ordered according to read-out segments on the left half of the circle; only for E2 siRNAs scoring in the top 25th percentile (E2 siRNA values pooled from all modules; CTRL siRNA set to 100%); ribbon width constant for all E2 siRNAs. (II) Legend for key DDR read-out segments located underneath the orange rim on the left (arranged on the left half of the Circos plot). Outer bar: colour indicates E2 siRNAs scoring in this module read-out; ordered clockwise corresponding to decreasing strength of individual E2 siRNA effect; width indicates strength of phenotype. Ribbons: ordered according to E2-siRNA segment list on other half of circle (see also above for E2 siRNAs). Read-out: colourcoded, segment width reflects cumulative impact of all E2 siRNAs scoring in this module. IR, ionizing radiation. (b) Live-cell laser micro-irradiation analyses of transiently expressed GFP-E2s. Data represent fluorescence intensity means of n = 9 (UBE2D1), n = 6 (UBE2D2), n = 3 (UBE2D3), n = 3 (UBE2D4), n = 6 (UBE2R1), n = 9 (UBE2R2), n = 12 (UBE2L3) and n = 18 (UBE2L6) measurements ± s.e.m. based on three measured sites across each laser tract. (c) IncuCyte cell proliferation/growth rate assays. Data represent medians ± s.e.m. of n = 10 experiments for controls and n = 8 for E2 siRNAs. Statistics source data for this panel can be found in Supplementary Plots represent RPA2 or BrdU fluorescence intensity medians (lines in boxes; numbers above whiskers), 25th-75th percentiles (boxes) and overall ranges (whiskers) of n = 73 (CTRL siRNA), n = 74 (siRNF138-1), n = 72 (siRNF138-2) γH2AX-positive cells for RPA2, and n = 72 (CTRL siRNA, siRNF138-1 and siRNF138-2) γH2AX-positive cells for BrdU, accumulated over two independent experiments. P values are based on Mann-Whitney analyses. All scale bars, 10 µm.
RPA2 foci (to avoid potential cell-cycle effects, these analyses focused on γH2AX-positive S-phase cells; Fig. 5a ). Similar RPA2 foci and ssDNA formation defects were also observed with MG132 treatment ( Supplementary Fig. 5a ), consistent with previous reports following intermediate 29 but not extreme 17 ionizing radiation doses. From these and preceding data on HR and DDR signalling, we concluded that UBE2Ds function upstream of ssDNA formation to promote ATR signalling and DSB repair by HR.
To explore the mechanism for these effects, we endeavoured to identify the UBE2D partner E3(s). Thus, we selected UBE2D-interacting E3s retrieved from several databases (UniProtKB, MINT, STRING and I2D). To reduce the E3 hits (96, 109, 106 and 99 for UBE2D1, -D2, -D3 and -D4, respectively; 121 unique hits in total), we prioritized E3s previously identified as potential ATM/ATR targets 30 . TRIP12, STUB1 (CHIP), RAD18 and BRCA1 were not selected owing to their established DDR phenotypes not being consistent with UBE2Ds depletion 1, 8, [31] [32] [33] [34] . In particular, BRCA1 depletion did not markedly affect CPT-induced pRPA or ssDNA formation in our assays ( Fig. 3b and data not shown). Strikingly, when we investigated the resulting six E3s in a semi-automated screen, only RNF138 (RING finger protein 138) depletion substantially impaired ssDNA formation (Fig. 5b) . Furthermore, like UBE2Ds depletion, RNF138 depletion with two independent siRNAs (Supplementary Fig. 5b ) markedly reduced RPA2 and ssDNA CPT-induced foci (Fig. 5c ). Moreover, depleting UBE2Ds and RNF138 simultaneously did not lead to additive effects in BrdU-based ssDNA detection assays ( Supplementary Fig. 5c ). These results thereby highlighted RNF138 as a DDR factor and potential functional partner of UBE2Ds.
RNF138 and UBE2Ds affect similar DDR processes
RNF138 is a ubiquitin E3 ligase, highly conserved in higher eukaryotes, containing a RING domain, three zinc fingers (ZNFs) and a ubiquitin-interacting motif 35, 36 (UIM; Fig. 6a ). Live imaging of cells transiently expressing wild-type (WT) GFP-RNF138 (endogenous RNF138 depleted) revealed that it rapidly accumulated at laser tracks (within 5 min) and persisted for >1 h (Fig. 6b) . Notably, UBE2D depletion or ATM, ATR or DNA-PK inhibition did not appreciably affect RNF138 accrual or retention at DSBs (Supplementary Fig. 6a and data not shown). In contrast, with MG132 treatment, initial RNF138 recruitment was weaker, whereas its retention 25 min after micro-irradiation was significantly impaired (Fig. 6b) , implicating ubiquitylation events in promoting RNF138 retention at DSB sites. Accordingly, deleting its UIM or mutating the RING domain (RM; C18/C21A) strongly impaired RNF138 retention (Fig. 6b) . The most striking phenotype occurred when deleting the ZNFs, whichin addition to causing a more predominant localization in the cytoplasm-severely reduced both RNF138 accrual and retention at DSB sites (Fig. 6b) . Consistent with ZNFs often binding to nucleic acids, WT-RNF138 but not RNF138-ZNFs bound to streptavidin beads coated with biotinylated DNA (Fig. 6c) . Collectively, these data supported a model wherein the ZNFs promote RNF138 recruitment by mediating contacts with exposed DNA at damage sites, and that ubiquitylation events-generated by RNF138 and/or other ubiquitin E2-E3 pairs-are required for effective RNF138 retention.
Together with the database interaction linkages, the similar impacts of UBE2Ds and RNF138 depletions on resection suggested that they functionally cooperate. Furthermore, RNF138 depletion mimicked UBE2D1-4 depletion, reducing FK2 and BRCA1 IRIF without markedly influencing 53BP1 or γH2AX IRIF (Fig. 6d ,e and Supplementary Fig. 6b ,c). Although a previous report connected UBE2D3 with BRCA1 (ref. 37 ), significant differences in phenotypes between depleting UBE2Ds or BRCA1 in resection (Module 3, Figs 3b and 5a and data not shown) suggested that UBE2Ds also act upstream of, and independently of, BRCA1. RNF138 depletion also phenocopied UBE2Ds depletion in every other DDR read-out we tested. Thus, RNF138 depletion severely impaired HR and also affected mutEJ ( Fig. 6f and Supplementary Fig. 6d ; controls as in Fig. 2b,c) . Finally, like UBE2Ds (Fig. 4c) , RNF138 was required for cellular resistance to ionizing radiation in clonogenic survival and cell proliferation/growth rate assays ( Fig. 6g and Supplementary Fig. 6e ). Moreover, depleting UBE2Ds and RNF138 simultaneously did not lead to clear additive effects regarding ionizing radiation sensitization or HR efficiency ( Supplementary Fig. 6f,g ). We therefore concluded that RNF138 acts directly or indirectly with UBE2Ds to promote DSB resection and repair by HR, as well as potentially influencing mutEJ and other DDR processes.
UBE2Ds and RNF138 promote CtIP DNA-damage accrual and ubiquitylation
Key events leading to DSB resection are accumulation of the MRE11-RAD50-NBS1 (MRN) complex and CtIP at DSBs (ref. 38) . Strikingly, we found that depleting UBE2Ds, or RNF138 with two independent siRNAs, strongly impaired recruitment of endogenous or GFP-CtIP to laser tracks but had no discernible effect on GFP-MRE11 recruitment (Fig. 7a ,b rows 1-2 and Supplementary Fig. 7a ,b). In contrast, CtIP depletion did not affect RNF138 accrual/retention ( Supplementary  Fig. 7c ). Importantly, the CtIP recruitment defect and the siCtIPrelated pRPA2-and pCHK1-induction defects in UBE2Ds-depleted cells ( Supplementary Fig. 2b ) were partially corrected by stable inducible expression of siALL-Ds-resistant WT but not catalytically dead (CD) UBE2D1 (Fig. 7a , rows 3-4, 7c and Supplementary  Fig. 7d ). Similarly, the CtIP recruitment defect caused by RNF138 depletion was almost entirely corrected in stable cell lines by inducible expression of siRNF138-1-resistant WT-RNF138, but not the RM mutant (Fig. 7b , rows 3-4).
The above results and our previous findings supported a model in which the ubiquitin-ligase activities of both UBE2Ds and RNF138 act downstream of MRE11 recruitment to promote CtIP accumulation at DSBs. In line with this and our previous observation that MG132 inhibited DSB resection and HR, MG132 also impaired CtIP accumulation ( Supplementary Fig. 7e ). As MG132 blocks RNF8-dependent accumulation of RNF168, 53BP1 and BRCA1 at DSBs (ref. 8) , we examined whether DNA-damage accumulation of CtIP was impaired by depleting such proteins. In contrast to the impacts of UBE2Ds or RNF138 depletion, DNA-damage accrual of CtIP occurred effectively in cells depleted of RNF8, RNF168 or BRCA1 ( Supplementary Fig. 7f,g ).
Previous work has established that RNF8, RNF168 and BRCA1 are required for effective FK2 IRIF formation 8, 37, 39 . As we had found that UBE2Ds and RNF138 promote CtIP recruitment to DSBs as well as FK2 and BRCA1 IRIF, we examined whether CtIP was required for IRIF formation by these and other DDR components. Significantly, this revealed that FK2, BRCA1 and 53BP1 IRIF still formed efficiently in CtIP-depleted cells ( Supplementary Fig. 8a-c) . Taking these data together, we concluded that cellular DDR functions of UBE2Ds and RNF138 relating to resection and CtIP accrual are specific and largely independent of RNF8, RNF168 or BRCA1. Conversely, RNF8, RNF168 and BRCA1 clearly promote FK2 IRIF formation and HR through BRCA1 recruitment 1, 2, 8 and therefore, operate through mechanisms distinct from the UBE2D-RNF138-CtIP-resection axis.
Further strengthening the links between UBE2Ds, RNF138 and CtIP, we found that UBE2D1 co-immunoprecipitated with and siALL-Ds and n = 4 experiments for siRNF138-1 (FK2 and 53BP1 foci and γH2AX nuclear intensity) and n = 4 for all siRNAs (BRCA1 foci), merged from, on average, 13,971 cells per condition. Statistics source data for this panel can be found in Supplementary Table 5 . (f) TLR results for HR efficiency in siRNF138-treated U2OS cells. Note that, as HR occurs only in S/G 2 , data were corrected to flow-cytometry S/G 2 values. Dashed line represents arbitrary cutoff at 60%. Data represent means ± s.d. for n = 5 independent experiments for CTRL siRNA and n = 3 for siRNF138. Statistics source data for this panel can be found in Supplementary Supplementary Table 5 .
(b) siRNF138-1-resistant WT-but not RM-GFP-RNF138 rescues CtIP accrual defects in siRNF138-1-treated cyclin A (CycA)-positive cells. Plots represent median CtIP fluorescence intensity ratios (lines in boxes; numbers above whiskers), 25th-75th percentiles (boxes) and overall ranges (whiskers) of n = 74 (1), 80 (2), 94 (3) and 76 (4) cyclin A-positive cells, accumulated over two independent experiments. P values are based on Mann-Whitney analyses. * * * * P < 0.0001; NS, not significant (P ≥ 0.05). Statistics source data for this panel can be found in Supplementary both RNF138 and CtIP (Fig. 7d) . In contrast, we did not detect interactions between RNF138 or CtIP and UBE2K ( Supplementary  Fig. 8d ), another E2 that markedly impaired FK2 IRIF and pRPA2 induction (Figs 1b, 3b and 4a) . Moreover, in reciprocal experiments, RNF138 immunoprecipitation retrieved both UBE2D1 and CtIP (Fig. 7e and Supplementary Fig. 8e ). As expected, the GFP-RNF138-RM did not efficiently co-immunoprecipitate with UBE2D1. However, it efficiently co-immunoprecipitated with CtIP, suggesting that RM-RNF138 was not generally misfolded and retained some functionality ( Fig. 7e ; note: these studies were done in RNF138-depleted cells). Importantly, we found that both UIM and ZNFs RNF138 mutants co-immunoprecipitated with UBE2D1 and CtIP to extents comparable to those of WT-RNF138 (Fig. 7e) , suggesting that these two mutants retained some cellular functions.
To determine whether CtIP is ubiquitylated in a UBE2Ds/RNF138-dependent manner, we co-expressed HA-ubiquitin with either GFP or GFP-CtIP in cells, and then treated or mock-treated cells with ionizing radiation. Next, we prepared cell extracts and assessed GFP immunoprecipitates for HA-ubiquitin staining by immunoblotting. This revealed ubiquitylation bands migrating above GFP-CtIP that were induced with ionizing radiation treatment (Fig. 7f) . Importantly, although we detected endogenous RNF138 in CtIP immunoprecipitates (Fig. 7g,h ), RNF138 ubiquitylation was not increased by ionizing radiation treatment ( Supplementary Fig. 8e ), supporting the idea that the ionizing-radiation-induced species in CtIP immunoprecipitates represented ubiquitylated CtIP. Supporting our finding that CtIP depletion did not impair FK2 IRIF, ubiquitylated forms of CtIP were almost undetectable by the FK2 antibody (Fig. 7f) . Crucially, we found that depleting UBE2Ds or RNF138 abolished ionizing-radiation-induced CtIP ubiquitylation (Fig. 7g,h ), suggesting that UBE2Ds/RNF138 might mediate ubiquitylation as a functional pair (note that the increase in ubiquitylation in siALL-Ds-over siCTRL-treated cells in the absence of DNA damage is due to experimental variation rather than biological significance). Supporting this hypothesis, UBE2D1, but not UBE2T-another E2 enzyme that scored highly in our screen-supported RNF138 autoubiquitylation in in vitro assays (Supplementary Fig. 8f ). Furthermore, UBE2D1 mediated in vitro ubiquitylation of purified CtIP in an RNF138-dependent manner (Supplementary Fig. 8g ). These data thus indicated that UBE2Ds and RNF138 can selectively act as a functional pair and play important roles early on in the DDR to promote ionizingradiation-induced CtIP ubiquitylation.
Finally, to gain deeper mechanistic insights into the importance of UBE2Ds-/RNF138-dependent CtIP ubiquitylation for DNA-end resection and CtIP recruitment, we identified 13 ubiquitylated lysines on CtIP by mass spectrometry, immunoprecipitated from irradiated cells (Fig. 8a) . One of these lysines does not play a role in CtIP recruitment 40 , so was excluded from further analyses. In addition to mutating all 12 potentially relevant lysines to arginines (CtIP-12KR), we generated CtIP mutants with lysine-to-arginine mutations clustered in the amino-or carboxy-terminal CtIP regions (CtIP-5KR and -6KR, respectively; Fig. 8a) . Immunoprecipitation experiments showed that ionizing-radiation-induced ubiquitylation observed with WT-CtIP was significantly reduced in the context of these mutants, especially CtIP-12KR and -5KR (Fig. 8b) . These results suggested that CtIP-N-terminal ubiquitylation may be important for DNAend resection and CtIP accrual at DSBs. Furthermore, we found that cells stably expressing siRNA-resistant CtIP-5KR failed to complement CPT-induced pRPA2 and pCHK1 in cells depleted of endogenous CtIP (Fig. 8c) . Moreover, compared with WT-CtIP, the 5KR mutant exhibited significant laser micro-irradiation recruitment defects, implying that ionizing-radiation-induced CtIP ubiquitylation is important for CtIP accumulation at DSBs (Fig. 8d) .
DISCUSSION
Although ubiquitylation affects virtually all aspects of eukaryotic cell biology, defining the precise nature of such events, and the ubiquitylation components mediating them, has been difficult because of technical challenges and the large number of ubiquitylation factors (>1,000 in human cells). Here, we provide a paradigm for how key aspects of ubiquitin biology can be defined through focused, indepth screens for E2-enzyme functions, leveraging this and other knowledge to define E2-E3-target-protein cascades. Accordingly, we have established UBE2D family proteins as important DDR enzymes, and identified RNF138 as a resection/HR-promoting factor that functionally interacts with UBE2Ds and CtIP. Our data are consistent with a model in which UBE2Ds and RNF138 constitute a functional E2-E3 ubiquitylation axis that, either directly or in cooperation with additional factors, promotes ionizing-radiationinduced CtIP ubiquitylations, including on five key lysines towards the CtIP N terminus. As the N terminus of CtIP is important for CtIP dimerization, tetramerization, recruitment to DSBs and repair by HR (refs 15,41), we speculate that CtIP ubiquitylation in this region may promote these functions by affecting its multimeric state and/or its interactions with other factors. Alternatively or in addition, ionizing-radiation-induced ubiquitylation could expose a recently identified internal DNA-binding motif in CtIP (ref. 38) to facilitate its DSB recruitment/functions. UBE2Ds/RNF138 could also generate ubiquitylation moieties recognized by CtIP through its proposed ubiquitin-binding function 42 . Our data thereby suggest further mechanistic studies to determine precisely how ubiquitylation of these N-terminal CtIP lysines promotes resection and HR. We note however, that UBE2Ds and RNF138-either as a functional pair or in combination with other ubiquitylation componentsprobably target additional proteins to affect other pathways within and beyond the DDR. Indeed, the accompanying paper 43 establishes that RNF138 mediates ubiquitylation of the DSB-repair protein, Ku, promoting Ku removal from DSBs to facilitate CtIP access, resection and HR.
Many additional avenues await exploration through exploiting our E2 screening data. For instance, these studies have highlighted links between various understudied E2 proteins and diverse aspects of the DDR, including DSB repair by HR and mutEJ, IRIF formation and ATM/ATR-mediated signalling. For example, we found that depletion of various E2s reduced FK2 IRIF, often without affecting 53BP1 IRIF. As FK2 antibodies most likely recognize many conjugated ubiquitin species, including different chain linkages and/or lengths, we speculate that these ubiquitylation events require multiple E2s, serving as initiators or elongators, and/or ubiquitylating the same protein at multiple sites. Moreover, we speculate that FK2 IRIF reduction reduction in RNF8/168-depleted cells may partly reflect the reduction of ubiquitylation events promoting BRCA1 recruitment, thought to further amplify FK2 IRIF (refs 37,39) . In line with this hypothesis, previous studies have reported an uncoupling between FK2 and 53BP1 IRIF (refs 44,45) . Collectively, our results suggest that various ubiquitylation events are required for the accumulation of various DDR proteins at DSBs. We also note that FK2 IRIF reduction in ALL-Ds-or RNF138-depleted cells coincided with reduced BRCA1 IRIF. Thus, it will be interesting to explore additional roles of UBE2Ds and RNF138 distinct from the CtIP ubiquitylation-resection axis defined here. It will also be interesting to further study the complex requirements for RNF138 accrual at DSBs, which may have evolved to ensure optimal spatial and temporal control of DSB processing, their downstream signalling and HR. We speculate that follow-on studies emanating from our E2 screen will be greatly facilitated by the use of orthogonal data sets, generated from other functional screens together with proteomic, mutational and gene-expression resources 13, 30, [46] [47] [48] . Finally, it is noteworthy that such work may have medical applications because small-molecule targeting of DDR enzymes and ubiquitin system components is providing opportunities for cancer therapies 49, 50 . Indeed, our findings highlight how certain ubiquitin E2 enzymes with DDR functions may represent attractive therapeutic targets.
METHODS
Methods and any associated references are available in the online version of the paper. 
M E T H O D S
METHODS
Cell culture. U2OS, U2OS-derived and HEK293 cells were cultured at 37 • C in a humidified atmosphere containing 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich) supplemented with 10% (v/v) fetal bovine serum (FBS) from BioSera or-for U2OS cells stably expressing tetracycline repressor (U2OS Trex) and derived inducible stable cell lines-tetracycline-negative FBS from PAA Laboratories, 100 U ml −1 penicillin, and 100 µg ml −1 streptomycin (Sigma-Aldrich). Additional supplements were used to maintain the following stable cell lines: 0.5 mg ml −1 G418 (Invitrogen) to select constitutively stably expressing GFP-CtIP (ref. 4 ) and GFP-FLAG-MRE11 U2OS cells; 2 µg ml −1 blasticidin (Invitrogen) for U2OS Trex cells, 2 µg ml −1 blasticidin (Invitrogen) and 0.2 mg ml −1 zeocin (Life technologies) for U2OS Trex cells stably expressing inducible GFP or siRNF138-1-resistant GFP-RNF138 (WT and RM), 2 µg ml −1 blasticidin (Invitrogen) and 0.5 mg ml −1 G418 (Invitrogen) for U2OS Trex cells stably expressing inducible siALL-Ds-resistant UBE2D1 (WT and C85S) and 2 µg ml −1 puromycin (SigmaAldrich) for U2OS TLR cells. Doxycycline (Sigma-Aldrich) was added at final concentrations of 0.001 µg ml −1 , 0.003 µg ml −1 or 1-2 µg ml −1 for 24-48 h to induce comparable levels of GFP, GFP-D1-CD or GFP-D1-WT/GFP-RNF138-WT/GFP-RNF138 C18/21A expression, respectively. U2OS and HEK293 cell lines were originally obtained from the ATCC cell repository and routinely tested to be mycoplasma free. The U2OS cell line was recently authenticated using Affymetrix SNP6 copy number analysis.
Generation of stable cell lines.
Single-cell sorting of polyclonal U2OS cells stably expressing GFP-FLAG-MRE11 or GFP-CtIP lysine-to-arginine mutants (12KR, 6KR or 5KR) was performed to select clones with homogeneous expression of the GFP-tagged proteins. Monoclonal cell lines stably expressing inducible siRNAresistant GFP-RNF138-WT, GFP-RNF138-C18/21A, GFP-UBE2D1-WT and GFP-UBE2D1-C85S were established using U2OS Trex (pcDNA6/TR Invitrogen) generated in this work.
siRNA and plasmid transfections. Unless otherwise stated siRNA oligonucleotides were designed using the Dharmacon design centre and purchased from MWG Biotech. siRNA transfections were performed using Lipofectamine RNAiMAX (Life Technologies) at a final siRNA concentration of ∼60 nM according to the manufacturer's instructions. siRNA-transfected cells were assayed 48-72 h after transfection. For siRNA and DNA co-transfections, plasmid transfections were performed 8 h after siRNA treatment using FuGENE6 (Roche), FuGENE HD (Roche) or TransIT-LT1 (Mirus Bio) following the manufacturer's guidelines. As a negative control we used siRNA oligonucleotides targeting Luciferase (CTRL siRNA). For a complete list of siRNA sequences used in this study see Supplementary Table 1 .
Small-molecule inhibition. The following conditions were used for the TLR assays: DNA-PK inhibitor (NU7441, Tocris Bioscience) at 3 µM for 72 h; proteasome inhibitor MG132 (Merck Biosciences/Calbiochem) at 0.1 µM for 48 h and ATM inhibitor (KU55933, Tocris Bioscience) at 10 µM for 72 h. For camptothecin, ionizing radiation or laser micro-irradiation experiments the following inhibitors were added 1 h before DDR treatments: MG132 at 20 µM, ATM inhibitor (see above) at 10 µM, ATR inhibitor (ATR-45, The Ohio State University, OSUCCC Medical Chemistry) at 1 µM, DNA-PK inhibitor (see above) at 3 µM.
DNA-damage induction using chemical agents, ionizing radiation and laser micro-irradiation.
Camptothecin (Sigma-Aldrich) was added to cells for 1 h at a final concentration of 1 µM. For ionizing radiation treatments a Faxitron-CellRad (Faxitron Bioptics, LLC) was used. Localized lines of DNA damage were induced by laser micro-irradiation, essentially as described previously 53, 54 . Briefly, U2OS cells were plated on glass-bottom dishes (Willco-Wells), treated with the indicated siRNAs or drugs, and pre-sensitized with 10 µM BrdU (Sigma-Aldrich) in phenol red-free medium (Invitrogen) for ∼48 h at 37 • C. Subsequent exposure to a laser beam was performed using a FluoView 1000 confocal microscope (Olympus) equipped with a 37 • C heating stage (Ibidi) and a 405 nm laser diode (6 mW) focused through a 60× UPlanSApo/1.35 oil objective and resulting in a spot size of 0.5-1 µm. Laser beam exposure times of 250 ms (fast scanning mode) were used at a setting of 0.4 mW output (50 scans) to yield pre-sensitization-dependent DNA damage, restricted to laser tracks without detectable cytotoxicity. For experiments involving CtIP, a laser power of 0.20-0.25 mW output was used, which resulted specifically in its recruitment to laser tracks in cyclin A (CycA)-positive S/G 2 but not in CycAnegative G1 cells. Cells were laser micro-irradiated for ∼20 min and left to recover under standard cell culture conditions for 1-2 h before fixing and staining.
TLR assays. The Traffic Light Reporter (TLR) comprises a mutant GFP gene with a unique recognition site for the endonuclease I-SceI followed by a 2-bp outof-frame mCherry gene. On transient expression of I-SceI, repair of the induced DSB generates one of two distinct fluorescent gene products depending on the repair pathway employed: GFP in the case of HR using a transiently transfected exogenous donor, which contains a truncated GFP functional for the part mutated in the TLR; or mCherry in the case of a 2 bp frameshift induced by mutEJ. Therefore, GFP and mCherry expression can be used as read-outs for HR and mutEJ efficiencies, respectively 14 . U2OS TLR cells were treated with the indicated siRNA or inhibitor and 8 h later co-transfected with expression plasmids containing: infrared fluorescent protein (IFP) and I-SceI endonuclease; and blue fluorescent protein (BFP) together with the donor sequence. Cells were collected ∼72 h after siRNA transfection. Four-colour fluorescent flow cytometry using a BD LSRFortessa cell analyser (BD Biosciences) allowed direct measurements of the percentages of GFP + (HR) and mCherry + (mutEJ) cells. A minimum of 10,000 doubly transfected (IFP + and BFP + ) cells were scored for each condition in a minimum of three experiments. Analyses were conducted using FlowJo (TreeStar). For each siRNA treatment, results were normalized to the control, a non-targeting siRNA specific for firefly luciferase (CTRL siRNA), resulting in relative HR and mutEJ percentages for each E2-siRNA pool (Fig. 2b,c, respectively, Supplementary Table 2 and the Pubchem BioAssays section). Finally, the HR values for each condition were normalized to the total amount of cells in the S and G 2 phases obtained using propidium iodidebased standard flow cytometry (see the Cell-cycle profiling section below). For a comprehensive overview of the screening data and individual values, see the PubChem BioAssays section.
Automated high-throughput/high-content microscopy for IRIF quantification and BrdU assays. Forty-eight hours after siRNA transfection, U2OS cells were seeded into 96-well plates (Cell Carrier, Perkin Elmer, 15,000 cells per well). The following day, cells were irradiated or directly processed to retrieve non-treated reference plates. Plates were fixed at the indicated time points and stained with the respective antibodies and DAPI. A spinning-disc Perkin Elmer Opera platform equipped with a 20× water immersion objective (0.7 numerical aperture, Olympus) was employed to acquire 6-10 confocal images (fields) for each well in a single optimized focal plane comprising two fluorescence channels, DAPI or Alexa Fluor 405 and Alexa Fluor 488. The micrographs were analysed using an optimized spot detection script operated by an integrated software package (Acapella, Perkin Elmer). DAPI or Alexa Fluor 405 was used to segment nuclei and create a nuclear mask. Automated mask transferral to the second fluorescence channel (γH2AX, 53BP1 or FK2) allowed detection of intensities and IRIF specifically within the nuclear areas of the detected cells. Key steps of the analysis pipeline are illustrated in Supplementary Fig. 1a . For the IRIF screen (module 1) we imaged >1 million cells resulting in, on average, >700 cells per condition based on one screening experiment. For a comprehensive overview of the screening data, see Supplementary  Fig. 1b ,c and the PubChem BioAssays section. For the IRIF data regarding siALL-Ds, siRNF138 and siCtIP-treated cells in Fig. 6d,e and Supplementary Fig. 8a ,b, we imaged >8,000 cells per siRNA per staining for Fig. 6e and >10,000 cells per siRNA per staining for Supplementary Fig. 8a .
IncuCyte cell proliferation/growth rate assays. Forty-eight hours after siRNA transfection 30,000 U2OS cells were plated into 24-well plates and irradiated with the indicated doses of ionizing radiation the following day. Phase-contrast images were acquired every 6 h over a time period of 168 h using an IncuCyte microscopy platform (Essen BioScience). Cell confluency percentages were calculated using the integrated Cell Player software and results were analysed with Excel (Microsoft Office) for exponential growth periods (confluency percentages <80% and incremental increase >2%). Values represent average increases in confluency for each measured 6-h increment of the indicated condition normalized to the corresponding undamaged control situation.
Microscopy. Unless stated otherwise fluorescence images of live and fixed cells
were acquired using the same microscope, objective and software as described for laser micro-irradiation experiments outlined in the DNA-damage induction section. Unless stated otherwise, all microscopy experiments were performed at least twice.
Clonogenic survival assays. U2OS cells were treated with siRNA oligonucleotides and irradiated with ionizing radiation at the indicated doses. Colony formation occurred over the next 10-14 days under standard cell culture conditions. Colonies were counted after staining with 0.5% crystal violet/20% ethanol. The results were normalized to plating efficiencies.
Quantitative real-time PCR (qRT-PCR).
Total RNA of U2OS cells treated with the indicated siRNA oligonucleotides was extracted and purified using the RNeasy Mini Kit (Qiagen) and the TURBO DNA-free Kit (Invitrogen) according to the manufacturer's instructions. Superscript III Reverse Transcriptase (Invitrogen) and oligo-d(T) primers contained within the kit were used to prepare cDNA following the manufacturer's guidelines. qRT-PCR experiments were carried out using Fast DOI: 10.1038/ncb3260 SYBR Green PCR mastermix (Invitrogen) on a StepOnePlus Real-Time PCR System (Applied Biosystems). Amounts of target mRNA were normalized to an endogenous housekeeping gene (GAPDH) and calculated using the formula: 2 − CT . Primer sequences are listed in Supplementary Table 3 .
Whole cell extracts and immunoblotting. For siRNA validation, 6 cm dishes of U2OS cells were washed once with PBS, collected in 100-150 µl 2× Laemmli buffer (120 mM Tris-HCl pH 6.8, 4% SDS and 20% glycerol), incubated for 5 min at 95 • C, briefly spun and sonicated. Protein concentrations were determined using a NanoDrop spectrophotometer (Thermo Scientific) at 280 nm followed by addition of bromophenol blue and 2-mercaptoethanol. For all DDR signalling experiments, immunoblotting conditions were as described above but the lysis buffer used contained 50 mM Tris-HCl pH 7.5, 2% SDS, serine/threonine phosphatase inhibitor cocktail (Sigma-Aldrich), protease inhibitor cocktail (Roche) and 10 mM N -ethylmaleimide (Sigma-Aldrich). After 5 min at 95 • C, SDS-PAGE was performed to resolve proteins on 4-20% Tris/glycine, precast NuPAGE Novex 4-12% Bis/Tris gradient gels (Invitrogen) or precast NuPAGE Novex 3-8% Tris/acetate gradient gels (Invitrogen). Specifically, experiments shown in Figs 7c-e and 8c and Supplementary Figs 2a,b,  7c and 8d,e were resolved on 4-20% Tris/glycine gels, whereas in Figs 7f-h and 8b 4-12% Tris/glycine gels were used. In Fig. 6c and in Supplementary Figs 3, 4a ,c,e, 7d and 8c,f, 4-12% Bis/Tris gels were used and in Supplementary Fig. 8g , a 3-8% Tris/acetate gel was used. Separated proteins were transferred to nitrocellulose or PVDF membranes (GE Healthcare) and immunoblotted with the indicated antibodies (Supplementary Table 4 ). Unless stated otherwise experiments were performed at least twice.
Immunoprecipitation. Cell extracts were prepared by scraping cells from PBSwashed plates into ice-cold lysis buffer (LB, 20 mM Tris-HCl pH 7.5, 40 mM NaCl, 2 mM MgCl 2 , 10% glycerol and 0.5% NP-40) containing freshly added N -ethylmaleimide (NEM, 10 mM, Sigma-Aldrich), EDTA-free protease inhibitor cocktail (PI, 1×, Roche), EDTA-free serine/threonine phosphatase inhibitor cocktail (PPI, Sigma-Aldrich) and Benzonase (10 µl ml −1 lysis buffer, Novagen 70664-3). After increasing the salt concentration to ∼500 mM NaCl, extracts were rotated for 10-15 min at room temperature, subsequently diluted 1:2 with lysis buffer (without Benzonase supplemented with 6 mM 1,10-phenanthroline, Sigma-Aldrich) and the extracts were cleared by centrifugation at 16,000g for 0.5-1 h at 4 • C. Immunoprecipitation reactions were rotated for 2 h to overnight at 4 • C using GFP-Trap-A beads (ChromoTek, 10 µl per milligram of protein) followed by five washes with immunoprecipitation buffer (lysis buffer without Benzonase containing a final concentration of ∼250 mM NaCl). Proteins were eluted from the GFP-Trap-A beads in a 5-10-min incubation step at 95 • C in 1.5× SDS sample buffer and immunoblotted as described in the respective section. For immunoprecipitation experiments shown in Fig. 7e and Supplementary Fig. 8e the procedure is as described above but the NaCl concentration (500 mM) was kept throughout including all 5 subsequent washes. Unless stated otherwise experiments were performed at least twice.
Immunofluorescence. Cells were washed with PBS containing 0.1% Tween-20 (PBST) and-for FK2, RPA2 and BrdU staining-pre-extracted for 10-15 min with buffer containing 25 mM HEPES pH 7.4, 50 mM NaCl, 1 mM EDTA, 3 mM MgCl 2 , 300 mM sucrose and 0.5% Triton X-100 followed by a 20-min fixation step in PBS containing 2% formaldehyde (w/v). For all other immunofluorescence experiments pre-extraction was omitted and cells were permeabilized for 10-15 min with 0.2-0.5% Triton X-100 in PBS after fixation. After three washes with PBST immunostaining was conducted with the indicated primary antibodies (Supplementary Table 4 ) diluted in blocking buffer (5% BSA in PBST) for 1 h at room temperature or overnight at 4 • C. After three PBST washing steps, cells were stained with the appropriate secondary antibodies (Supplementary Table 4 ) diluted in blocking buffer (1 h at room temperature) followed by three washes with PBST. Unless stated otherwise cells were counterstained with DAPI (2-5 µg ml −1 ) and mounted using Vectashield (Vector Labs).
Statistics and analyses.
Unless stated otherwise Prism 6 (GraphPad Software) was used to calculate P values based on Mann-Whitney analyses. Data were considered statistically significant for P values < 0.05. Unless otherwise specified, statistical analyses are based on at least three biologically independent experiments. The CLC Main Workbench software package was used for protein alignments and the open source software package R for bubble plots (Fig. 3b and Supplementary Fig. 2d ). Unless stated otherwise, microscopy image analyses were performed using the open software packages ImageJ and FIJI or FV-10 software (Olympus). Specifically, nuclei were manually segmented using the DAPI channel and the resulting regions of interest transferred to the fluorescence channel of interest (RPA2, BrdU or CtIP). For intensity quantifications of CtIP laser lines, average CtIP intensities along laser tracks were measured and ratios of CtIP average line intensities over average nucleoplasm intensities were calculated and compared. Unless stated otherwise, Excel (Microsoft Office), Prism 6 (GraphPad Software) or CLC Main Workbench were used for data visualization.
Reproducibility of experiments.
Excluding screening experiments that have been performed once, all other experiments were performed at least twice unless specified otherwise. Note that the increase in ubiquitylation in siALL-Ds-over siCTRL-treated cells in Fig. 7g in the absence of DNA damage is due to experimental variation rather than biological significance.
Circos plot. Circular visualization 51 was used to illustrate complex DDR fingerprints of E2-siRNA pools contained in key read-outs of all three screening modules. Effects were normalized to CTRL siRNA treatments for each read-out. Increases in read-outs were set to 0.
Cell-cycle profiling. U2OS cells were treated with siRNA and fixed with 70% ethanol. After RNAse A (250 µg ml −1 ) and propidium iodide (10 µg ml −1 ) incubation for 30 min at 37 • C cells were analysed by flow cytometry on a FACSCalibur flow cytometer (BD Biosciences) using the CellQuest software. Results were analysed using FlowJo (TreeStar) to calculate the percentage of cells in different cell-cycle phases using two algorithms, Watson Pragmatic (WP) and Dean-Jett-Fox (DJF).
DNA pulldown experiments. Magnetic streptavidin Dynabeads (Dynal, M-280; 50 µl bead-slurry per reaction) were washed twice with 2× Binding and Washing buffer (2× B&W buffer; 10 mM Tris-HCl pH 7.4 and 2 M NaCl) and subsequently rotated for 15 min at room temperature in the presence of 5 pmol of 5 -biotinylated or untagged DNA oligonucleotides of the sequence 5 -ATCGCATTGGCATTGG CAATGCGATACGACTGATCGAGGGTACTCAGCTAGCTGATTCCGATCG GCTTATTCCGTGTACATACATCGGAT-3 . After washing three times with 1x B&W and twice with blocking buffer (50 mM Hepes, 150 mM NaCl, 0.05 mg ml −1 BSA and 0.02% NP-40), the beads were rotated for 30 min at room temperature in the presence of blocking buffer. On removal of the blocking buffer, the beads were rotated for 45 min at room temperature in 500 µl blocking buffer containing 600 ng of bacteria-purified His-SUMO-RNF138-WT or -ZNFs, followed by four washes with blocking buffer. His-SUMO-RNF138-WT or -ZNFs were eluted from the beads in a 10-min incubation step at 95 • C in 1.5× SDS sample buffer and immunoblotted as described in the respective section.
Bacterial protein expression and purification. His-SUMO-RNF138 and UBE2T
were expressed and purified following the protocols of ref. 55 , with minor variations. Briefly, proteins were expressed in Rosetta cells (Novagen) following an overnight IPTG induction at 16 • C, the bacteria lysed in buffer containing 0.5 M NaCl, 100 mM Tris pH 8.0, 250 µM TCEP and protease inhibitors (Roche) and the clarified lysates incubated with Ni-NTA (Qiagen). Proteins were eluted with 300 mM imidazole and dialysed to remove the imidazole. RNF138 retained the His-SUMO tag, whereas the His tag was removed from UBE2T using PreScission Protease (GE Healthcare) overnight at 4 • C.
In vitro ubiquitylation assays. In vitro ubiquitylation assays were performed in 20 µl reactions in the presence of 50 mM HEPES-NaOH pH 8.0, 100 mM NaCl, 3 mM ATP/Mg (Sigma-Aldrich, A9187), 0.1 µM UBE1 (Boston Biochem, E-304), 30 µM biotin-Ub (Boston Biochem, UB-560), 3 µM UBE2D1 (Boston Biochem, E2-616) or 0.5 µM UBE2T and 0.2 µM His-SUMO RNF138. Reactions were incubated at 37 • C for 30-60 min and overnight at room temperature in the presence of 0.5 mM dithiothreitol for CtIP. The reactions were terminated by the addition of SDS-PAGE sample buffer containing reducing agent and subsequent boiling at 95 • C for 3 min. Samples were subjected to SDS-PAGE and analysed by immunoblotting.
LC-MS/MS to map ubiquitylated lysines on CtIP. HEK293 cells transiently
expressing GFP-CtIP were irradiated (ionizing radiation, 15 Gy) and after 20 min recovery cells were collected, lysed and GFP-CtIP was immunoprecipitated according to the Immunoprecipitation section above, with the exception that washing was done five times with high-salt lysis buffer (LB + NEM + PI + PPI, 1 M NaCl) and twice with low-salt lysis buffer (LB + NEM + PI + PPI) in the end. Immunoprecipitated GFP-CtIP was resolved by SDS-PAGE and in-geldigested using trypsin. A quadrupole Orbitrap mass spectrometer (Q-Exactive Plus, Thermo Scientific) equipped with an EASY-nLC II nanoflow HPLC system (Thermo Scientific) was used to analyse the peptide fractions 56 . Analyses of raw data were performed using MaxQuant (development version 1.3.9.21; ref. 57 ). The Andromeda search engine 58 was used to search parent ion and MS2 spectra against 88,473 human protein sequences retrieved from the December 2013 UniProt knowledge base. Spectra were searched with a mass tolerance of 6 ppm in MS mode, 20 ppm in HCD MS2 mode, strict trypsin specificity and allowing up to two missed cleavage sites. Cysteine carbamidomethylation was included as a fixed modification and N-terminal protein acetylation, methionine oxidation, NEM modification of cysteines, di-glycine-lysine were included as variable modifications. The probabilities of site localizations were determined using MaxQuant based on the PTM scoring algorithm 57 . Filtering of the data set was based on posterior error probability (PEP) to arrive at a false discovery rate of 1% for peptide spectrum matches and protein groups. The 14 lysines in CtIP were identified on the basis of two biological replicates and occurred in either one or both of the experiments.
Plasmids and cloning. Plasmids used in the TLR assays have been described previously 14 . pEGFP-C1 (Clontech) vectors containing UBE2D1 (WT and C85S), UBE2D2, UBE2D3, UBE2D4, UBE2K, UBE2L3, UBE2L6 and UBE2R1 with 5 XhoI and 3 HindIII as cloning sites, UBE2J1 with 5 XhoI and 3 BamHI as cloning sites and UBE2J2, UBE2O and UBE2R2 with 5 HindIII and 3 EcoRI as cloning sites were purchased from Genewiz. Plasmids for tet-on inducible expression of siALL-Ds-resistant UBE2D1 (WT and C85S) in mammalian cells were generated according to the following. First, UBE2D1 (WT and C85S) cassettes were sub-cloned from pEGFP-C1 into a tetracycline operator (TO)-containing pEGFP-C1 (pEGFP-C1/TO) using XhoI and HindIII. Second, we inserted six silent mutations into the siUBE2D1-2 target sequence in UBE2D1 C85S and an additional five silent mutations into the partial siUBE2D2-1 target sequence in UBE2D1-WT using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) according to the manufacturer's instructions with pEGFP-C1/TO-UBE2D1 (WT and C85S) as templates and siUBE2D1-2res-D1_f and siUBE2D1-2res-D1_r (WT and C85S) or siUBE2D2-1res-D1_f and siUBE2D2-1res-D1_r (WT) as primers (Supplementary Table 3 ). pEGFP-C1 vectors containing RNF138 (WT, UIM, ZNF ( 86-215)) with 5 XhoI and 3 BamHI as cloning sites were purchased from Genewiz. pEGFP-C1 containing the RNF138 C18/21A double mutant was generated using the QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) according to the manufacturer's instructions with pEGFP-C1-RNF138-WT as a template and 138-C18/21A_f and 138-C18/21A_r as primers (Supplementary Table 3 ). Mammalian expression plasmids for RFPand HA-RNF138-WT were generated by sub-cloning RNF138-WT from pEGFP-C1 into pmRFP-C1 (pEGFP-C1 containing monomeric RFP (mRFP) instead of GFP) and HA-pcDNA3.1(-) (HA tag inserted into pcDNA3.1(-) (Life Technologies) between NheI and XhoI sites) using XhoI and BamHI. Mammalian expression plasmids for tet-on inducible expression of siRNF138-1-resistant GFP-RNF138 (WT and C18/21A) were obtained according to the following: first, we PCRamplified the GFP-RNF138 (WT and C18/21A) cassettes contained within pEGFP-C1 using primers HindIII-GFP_f and 138-BamHI_r (Supplementary  Table 3 ) and inserted the digested products into the HindIII and BamHI sites of pcDNA4/TO (Invitrogen). Second, we induced six silent mutations contained within the target sequence of siRNF138-1 into RNF138 (WT and C18/21A) using the QuikChange Lightning Site-Directed Mutagenesis Kit 70 . siCTRL and siRNF8/168 (co-depletion of RNF8 and RNF168)-treated cells were used as a negative and positive control, respectively. Note: siCTRL and siRNF8/168 curves are identical in each graph being part of the same experimental pipeline. Data represent averages ± range of n=8 (siCTRL and siRNF8+168) or n=2 (all other siRNAs) 96-microplatewells of, on average, 704 imaged cells per siRNA based on one screening experiment. See PubChem Bioassays for a comprehensive overview of the screening data. . Data represent ratios of phosphorylated KAP1 over total KAP1 levels, or gH2AX levels, which were normalised to siCTRL-treated cells and from which the equivalent ratios in undamaged cells were subtracted. Negative control siRNA (siCTRL) and positive controls are highlighted in red and blue, respectively. Grey background shows regions of >40% reductions. Supplementary Figure 4 Additional validation regarding co-depletion of UBE2Ds. a siRNA depletion efficiencies for deconvoluted siRNA oligonucleotides used for screening modules 1-3 targeting UBE2Ds. GFPtagged UBE2Ds and mRNA levels of target genes relative to GAPDH levels are indicated. On-target depletion efficiencies and off-target depletion of other members of the same family are analysed. siRNAs targeting 3' untranslated regions (UTRs; siD1-1, siD2-2 and siD3-1) did not deplete the corresponding, exogenously expressed GFP-UBE2D constructs, which only contained the respective coding sequences ( Supplementary Fig. 3 ), but efficiently depleted the on-target endogenous mRNAs. Histogram data represent averages of two technical replicates. b, Amino acid differences between UBE2D1, -D2, -D3, -D4, UBE2R1, -R2, UBE2L3, -L6 and UBE2J1, -J2. Supplementary Figure 6 Additional characterisation of RNF138 in the DDR, validation of siBRCA1 and BRCA1 antibody and RNF138-UBE2Ds epistasis assays. a, Transiently expressed siRNA-resistant GFP-RNF138 is recruited to, and retained at, laser micro-irradiation-induced sites of DNA damage independently of UBE2Ds (endogenous RNF138 depleted). b, c, Specificity of BRCA1 antibody and siBRCA1 depletion efficiency, as determined by immunofluorescence images (left; non-treated (NT) for DNA damage) (b) and automated Acapella spot detection of non-targeting siCTRL-and siBRCA1-treated cells (right; 30 min, 2 Gy) (c). Histogram data represent means ± SDs of n=4 independent experiments merged from, on average, 17,129 cells per condition. d, TLR results for mutEJ in siRNF138-treated cells. Controls are as in Figure 2c being part of the same pipeline (only siCTRL is shown). Data represent means ± SDs for n=8 experiments for siCTRL and n=3 for siRNF138. Statistics source data for this panel are available in Supplementary Table 5 .
e, Incucyte proliferation/growth rate analyses of U2OS cells treated with the indicated siRNA oligonucleotides. siCTRL and siATM were used as a negative and positive control, respectively. Controls are as in Figure 4c , being part of the same pipeline. Data represent medians ± SEM of n=10 experiments for controls and n=8 experiments for siRNF138. Statistics source data for this panel are available in Supplementary Table 5 . f, Incucyte proliferation/growth rate analyses of U2OS cells treated with the indicated siRNA oligonucleotides. siCTRL and siATM were used as a negative and positive control, respectively. Controls are as in Figure 4c , being part of the same pipeline. Data represent medians ± SEM of n=10 experiments for controls and n=3 experiments for all others. Statistics source data for this panel are available in Supplementary  Table 5 . g, TLR-HR results for the indicated siRNA oligonucleotides. Data represent means ± SDs of n=4 independent experiments. Statistics source data for this panel are available in Supplementary Table 5 . All scale bars=10 μm. 
